Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, July 9, 2019

Public edition | newswise.com

Newswise Cancer Research Wire for 09-Jul-2019
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.


Cancer Research


Study: Many Thyroid Cancer Patients Say They Had No Choice About Radioactive Iodine

A new U-M survey suggests many thyroid cancer patients are receiving radioactive iodine treatment when there’s no strong indication of benefit — and a majority may feel like they don’t really have a choice about it.

– Michigan Medicine - University of Michigan

Journal of Clinical Oncology

Embargo expired on 08-Jul-2019 at 16:00 ET


Triplet-targeted therapy improves survival for patients with advanced colorectal cancer and BRAF mutations

The three-drug combination of encorafenib, binimetinib and cetuximab significantly improved overall survival (OS) in patients with BRAF-mutated metastatic colorectal cancer (mCRC), according to results of the BEACON CRC Phase III clinical trial led b...

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 06-Jul-2019 at 05:00 ET


Scientists Invent Fast Method for ‘Directed Evolution’ of Molecules

Nobel Prize-winning Directed evolution is an artificial, sped up process to make a protein perform a specified task. UNC School of Medicine scientists created a powerful new directed evolution technique for the rapid development of scientific tools a...

– University of North Carolina School of Medicine

Cell

Embargo expired on 04-Jul-2019 at 11:00 ET


Study Highlights Need for Tailored Skin Cancer Prevention Programs

Researchers at the GW Cancer Center found that sun safety practices for attendees at skin cancer screening events differ from the general public.

– George Washington University

Journal of Drugs in Dermatology, Jul-2019


Therapeutic Strategies Based on Evolutionary Principles May Be Key to Improving Patient Outcomes

In a new article published by Cancer Research, Moffitt Cancer Center researchers propose the evolutionary dynamics of background extinctions suggest this focus on finding new and better drugs may have neglected opportunities to develop new and better...

– Moffitt Cancer Center

Cancer Research, June-2019


Addicted to Ran, Ovarian Cancer Cells Stop Moving When Deprived

Researchers have shown the key role that a protein called Ran plays in the mobility of ovarian cancer cells: they demonstrated these cells cannot migrate from cancerous sites without the help of Ran.

– Universite de Montreal

Nature Communications, July 9, 2019; Canadian Institutes of Health; Institut du cancer de Montreal


Moffitt Researchers Identify Effective Drug Combination Against Uveal Melanoma in Preclinical Studies

Moffitt Cancer Center researchers have identified a new drug combination that is effective against metastatic uveal melanoma cells in preclinical studies.

– Moffitt Cancer Center

Clinical Cancer Research, June-2019


Scientists discover origin of cell mask that hides stomach cancer

A layer of cells that look like normal stomach lining on top of sites of stomach cancer can make it difficult to spot after removal of a Helicobacter pylori infection. In a recent study

– Hiroshima University

Journal of Gastroenterology


Similarities of Small Cell Cancers to Blood Cancers Could Lead to Better Treatments

An interdisciplinary team of UCLA scientists has found that small cell neuroendocrine cancers from a range of tissues have a common molecular signature and share drug sensitivities with blood cancers.

– University of California, Los Angeles (UCLA), Health Sciences

Cancer Cell


UCI team pioneers cancer treatment that targets bone metastases while sparing bone

Irvine, Calif., July 8, 2019 — University of California, Irvine researchers have developed and tested on mice a therapeutic treatment that uses engineered stem cells to target and kill cancer bone metastases while preserving the bone.  This new ap...

– University of California, Irvine

EBioMedicine, July-2019


Ludwig Study Uncovers Novel Cellular Oxygen Sensor

A Ludwig Cancer Research study led by Peter Ratcliffe and colleagues has discovered a previously overlooked oxygen sensor in animal cells that functions very much like one used by plants.

– Ludwig Cancer Research

Science, Jul-2019


Discovery of pancreatic neuroendocrine subtypes could help predict likelihood of recurrence

Researchers have discovered two distinct subtypes of pancreatic neuroendocrine tumors – known as pNETs – that have dramatically different risks of recurrence following surgical treatment [or surgery]. The finding could yield predictive tests, eas...

– Dana-Farber Cancer Institute

Nature Medicine, July-2019


Using Machine Learning Models to Better Predict Bladder Cancer Stages

Bladder cancer, one of the most common cancers in the U.S., may be soon helped by a novel non-invasive diagnostic method thanks to advances in machine learning research at the San Diego Supercomputer Center (SDSC), Moores Cancer Center, and CureMatch...

– University of California San Diego

Metabolics, June-2019


Cancer Experts and Features


How to Pick the Best Sunglasses to Protect Your Eyes

Sunglasses aren’t an optional summertime accessory, they’re an essential prescription for eye health. Long-term exposure to the sun without proper protection can increase the risk of eye disease, including cataract, growths on the eye, and eye ca...

– American Academy of Ophthalmology (AAO)


Mount Sinai Leaders Discuss Improving the Drug Ecosystem, the Revolution in Cancer Immunology and the Pediatrician of the Future at the 2019 Aspen Ideas Health and Aspen Ideas Festival

Mount Sinai dermatologists and clinicians provided more than 1,000 onsite complimentary skin cancer and heart screenings

– Mount Sinai Health System


Regulation of Cancer Promoting Molecule EphB4 Offers Potential Treatment Target for Mesothelioma, Other Cancers

– Sbarro Health Research Organization (SHRO)

Identification of a Novel EphB4 Phosphodegron Regulated by the Autocrine IGFII/IRA Axis in Malignant Mesothelioma

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 University of Texas M. D. Anderson Cancer Center

 Hiroshima University

 University of California, Los Angeles (UCLA), Health Sciences

 Michigan Medicine - University of Michigan

 George Washington University


Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us